MARUTI.NS Maruti Suzuki India Limited
INR·Price 13426.00·Mkt cap 4.22TComputed from the latest reported financials and the current market price.
Who's the real player?
A genuine play on this theme — most of its business sits right here.
Is the business healthy?
A mixed picture — real strengths, but soft spots in cash flow, returns or debt.
- Strong cash flow quality
- High FCF conversion
- Low accrual ratio
- Good growth consistency
Are the smart people buying?
No ownership-change data for this stock. Conviction is judged from capex and buyback signals alone.
What is management saying?
No earnings-call transcript or filings found for this stock.
Is the price right?
Intrinsic value 7215.98 vs price 13426.00 — screens expensive on a cash-flow DCF (-46.3% to intrinsic). The reverse-DCF implied growth of 23.56% is not believable given the base FCF growth assumption of 15%, suggesting overoptimism in long-term projections.
| Intrinsic / share | 7215.98 |
| Price | 13426.00 |
| Upside to intrinsic | -46.3% |
| Reverse-DCF implied g | 23.6% |
Base FCF 72.88B · growth 15.0% · discount 12.0% · terminal 5.0%.
Sensitivity — intrinsic value / share
Each cell is the intrinsic value at that growth (across →) and discount rate (down ↓). Center ★ is the base case. Cells green = above price (cheap), red = below (expensive).
| Growth rate → | |||||
|---|---|---|---|---|---|
| Disc ↓ ╲ g | 11% | 13% | 15% | 17% | 19% |
| 10% | 7764.49 | 9064.94 | 10575.03 | 12325.25 | 14349.91 |
| 11% | 6373.06 | 7408.7 | 8608.94 | 9997.53 | 11601.2 |
| 12% | 5384.51 | 6233.72 | ★ 7215.98 | 8350.34 | 9658.24 |
| 13% | 4647.39 | 5358.98 | 6180.46 | 7127.42 | 8217.44 |
| 14% | 4077.61 | 4683.96 | 5382.58 | 6186.47 | 7110.28 |
Through the masters' eyes
Each investor's numeric rules, checked against this stock's metrics: exact math, no guesswork. Tap one to see which rules pass, fail, and what to judge yourself.
Financial statements (INR)
↗ sourceCash-flow lines highlighted — we trust cash over reported profit.
| Line | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | 1.80T | 1.51T | 1.36T | 1.14T | — |
| Operating income | 147.15B | 145.48B | 134.06B | 82.63B | — |
| EBITDA | 260.99B | 254.22B | 228.74B | 155.37B | — |
| Net income | 146.79B | 145.00B | 134.88B | 82.64B | — |
| Operating cash flow | 191.00B | 161.80B | 168.01B | 108.15B | — |
| Capex | -103.98B | -106.21B | -92.00B | -80.65B | — |
| Free cash flow | 87.02B | 55.59B | 76.01B | 27.50B | — |
| Total assets | 1.49T | 1.32T | 1.15T | 1.00T | — |
| Total equity | 1.07T | 962.40B | 856.36B | 746.00B | — |
| Total debt | 1.02B | 870.00M | 1.19B | 12.48B | — |
| Cash & equivalents | 669.00M | 1.84B | 26.59B | 17.85B | — |